Release of cytokines and proteases from human peripheral blood mononuclear and polymorphonuclear cells following phagocytosis and LPS stimulation

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 56, Issue 5, 1996, Pages 461-470

  Ohlsson, K ^a   Linder, C ^a   Lundberg, E ^a   Axelsson, L ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Cytokines; Interleukin 1; Interleukin 1 receptor antagonist; Leukocyte proteases; Secretory leukocyte proteinase inhibitor; Soluble tumour necrosis factor receptor I; Tumour necrosis factor

Indexed keywords

CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; PROTEINASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MONOCYTE; NEUTROPHIL; NORMAL HUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; YEAST;

EID: 0029816325     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365519609088801     Document Type: Article

References (25)

1. Miechie HR, Manogue KR, Spriggs DR, Revhaugh A, O'Dwyer S, Dinarello SA, et al. Detection of circulating tumour necrosis factor after endotoxin administration. N Engl J Med 1988; 318: 1481-6.
2. Marrack P, Kappler I. The staphylococcal enterotoxins and their relations. Science 1990; 248: 247-9.
3. Keroack MA. Invasive group A streptococcal infection and streptococcal toxic shock syndrome. Curr Opin Inf Dis 1991; 4: 621-7.
4. Bohach GA, Fast DJ, Nelson RD, Schlievert PM. Staphylococcal and streptococcal pyrogenic toxins involved in toxin shock syndrome and related illness. Microbiology 1989; 17: 251-7.
5. Musser JM, Mauser AR, Kiow HM, Schlievert PM, Nelson K, Selander RK. Streptococcus pyogenus causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyogenic exotoxin expression. Proc Natl Acad Sci USA 1991; 88: 2668-72.
6. Beutler B, Milsark IW, Cerami A. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effects of endotoxin. Science 1985; 229: 869-71.
7. Dinarello CA. Interleukin-1 and its biologically related cytokines. Adv Immunol 1989; 44: 153-205.
8. Ohlsson K, Björk P, Bergenfeldt M, Hageman R, Thompson RC. An interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature 1990; 348: 550-2.
9. Björk P, Ohlsson K. The interleukin-1 receptor antagonist influences interleukin-1 effects in rat and mouse. Mediators of Inflammation 1992; 1: 27-31.
10. Arend WP. Interleukin-1 receptor antagonist. Adv Immunol 1993; 54: 167-227.
11. Olsson I, Lanz M, Nilsson E, Peetre H, Thysell H, Grubb A. Isolation and characterization of a tumor necrosis factor binding protein from urine. Eur J Haematol 1989; 42: 270-5.
12. Ulich TR, Guo K, Yin S, del Castillio J, Yi ES, Thompson RC, et al. Endotoxin-induced cytokine gene exoression in vivo. IV. Expression of interleukin-1 alpha/beta and interleukin-1 receptor antagonist mRNA during endotoxemia and during endotoxin-initiated local acute inflammation. Am J Pathol 1992; 141: 61-8.
13. Jansson RW, Hance KH, Arend WP. Production of IL-1 receptor antagonist by human in vitro-derived macrophages. Effects of lipopolysaccharide and granulocyte-macrophage colony-stimulating factor. J Immunol 1991; 147: 4218-223.
14. Ohlsson K, Olsson I. The neutral proteases of human granulocytes. Isolation and partial characterization of granulocyte elastases. Eur J Biochem 1974; 42: 519-27.
15. Ohlsson K, Linder C, Rosengren M. Monoclonal antibodies specific for neutrophil proteinase 4. Production and use for isolation of the enzyme. Biol Chem Hoppe-Zeyler 1990; 371: 549-55.
16. Burnette WN. Western blotting: electrophoretic transfer of proteins from sodium dodecyl sulfate polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radio-iodinated protein A. Analyt Biochem 1981; 112: 195-203.
17. Scheidegger JJ. Une micro-méthode de l'immunoelectrophoresis. Int Arch Allergy 1955; 7: 103-9.
18. Ouchterlony Ö. In vitro method for testing the toxin-producing capacity of diphteria bacteria. Acta Pathol Microbiol 1948; 25: 186-90.
19. Bergenfeldt M, Axelsson L, Ohlsson K. Release of neutrophil proteinase 4(3) and leucocyte elastase during phagocytosis and their interaction with proteinase inhibitors. Scand J Clin Lab Invest 1992; 52: 823-9.
20. Bergenfeldt M, Ohlsson K. Protease-antiprotease levels and whole-blood chemiluminiscence in acute peritonitis. Gastroenterol Japon 1993; 28: 687-98.
21. Ohlsson K, Olsson I. The extracellular release of granulocyte collagenase and elastase during phagocytosis and inflammatory processes. Scand J Haematol 1977; 19: 145-52.
22. Dubravec DB, Spriggs DR, Mannick JA, Rodrick ML. Circulating human peripheral blood granulocytes synthesize and secrete TNF alpha. Proc Nat Acad Sci USA 1990; 87: 6758-61.
23. Thornberry NA, Bull HG, Calaycay JR, et al. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 1992; 356: 768-74.
24. Andersson J, Björk L, Dinarello CA, Towbin H, Andersson U. Lipopolysaccharide induces human interleukin-1 receptor antagonist and interleukin-1 production in the same cell. Eur J Immunol 1992; 22: 2617-23.
25. Marucha PT, Zeff RA, Kreutzer DL. Cytokine regulation of IL-1 gene expression in human polymorphonuclear leukocyte. J Immunol 1990; 145: 2932-7.